162 related articles for article (PubMed ID: 24516901)
1. Artenimol + piperaquine. Very slow piperaquine elimination: cardiovascular risks and interactions.
Prescrire Int; 2014 Jan; 23(145):5-8. PubMed ID: 24516901
[TBL] [Abstract][Full Text] [Related]
2. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
3. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
[TBL] [Abstract][Full Text] [Related]
4. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
[TBL] [Abstract][Full Text] [Related]
5. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
[TBL] [Abstract][Full Text] [Related]
6. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria.
; Pekyi D; Ampromfi AA; Tinto H; Traoré-Coulibaly M; Tahita MC; Valéa I; Mwapasa V; Kalilani-Phiri L; Kalanda G; Madanitsa M; Ravinetto R; Mutabingwa T; Gbekor P; Tagbor H; Antwi G; Menten J; De Crop M; Claeys Y; Schurmans C; Van Overmeir C; Thriemer K; Van Geertruyden JP; D'Alessandro U; Nambozi M; Mulenga M; Hachizovu S; Kabuya JB; Mulenga J
N Engl J Med; 2016 Mar; 374(10):913-27. PubMed ID: 26962727
[TBL] [Abstract][Full Text] [Related]
7. Artenimol-piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort.
Pull L; Lupoglazoff JM; Beardmore M; Michel JF; Buffet P; Bouchaud O; Siriez JY
Malar J; 2019 Dec; 18(1):419. PubMed ID: 31843017
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria.
Keating GM
Drugs; 2012 May; 72(7):937-61. PubMed ID: 22515619
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ugandan children: a systematic review and meta-analysis of randomized control trials.
Assefa DG; Zeleke ED; Bekele D; Tesfahunei HA; Getachew E; Joseph M; Manyazewal T
Malar J; 2021 Apr; 20(1):174. PubMed ID: 33794897
[TBL] [Abstract][Full Text] [Related]
11. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
12. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil.
Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806
[TBL] [Abstract][Full Text] [Related]
13. Dose ranging studies of new artemisinin-piperaquine fixed combinations compared to standard regimens of artemisisnin combination therapies for acute uncomplicated falciparum malaria.
Krudsood S; Tangpukdee N; Thanchatwet V; Wilairatana P; Srivilairit S; Pothipak N; Jianping S; Guoqiao L; Brittenham GM; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2007 Nov; 38(6):971-8. PubMed ID: 18613536
[TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
15. Safety of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials.
Assefa DG; Zeleke ED; Molla W; Mengistu N; Sefa A; Mebratu A; Bate AF; Bekele E; Yesmaw G; Makonnen E
Malar J; 2022 Jan; 21(1):4. PubMed ID: 34983552
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine].
Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O
Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184
[TBL] [Abstract][Full Text] [Related]
17. A trial of combination antimalarial therapies in children from Papua New Guinea.
Karunajeewa HA; Mueller I; Senn M; Lin E; Law I; Gomorrai PS; Oa O; Griffin S; Kotab K; Suano P; Tarongka N; Ura A; Lautu D; Page-Sharp M; Wong R; Salman S; Siba P; Ilett KF; Davis TM
N Engl J Med; 2008 Dec; 359(24):2545-57. PubMed ID: 19064624
[TBL] [Abstract][Full Text] [Related]
18. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
Arinaitwe E; Sandison TG; Wanzira H; Kakuru A; Homsy J; Kalamya J; Kamya MR; Vora N; Greenhouse B; Rosenthal PJ; Tappero J; Dorsey G
Clin Infect Dis; 2009 Dec; 49(11):1629-37. PubMed ID: 19877969
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
[TBL] [Abstract][Full Text] [Related]
20. Paediatric formulations of artemisinin-based combination therapies for treating uncomplicated malaria in children.
Bélard S; Ramharter M; Kurth F
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD009568. PubMed ID: 33289099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
